Endocannabinoids and the non-homeostatic control of Appetite

Current Topics in Behavioral Neurosciences

Volumn 1, Issue , 2009, Pages 231-253

  Kirkham, Tim C ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Appetite; Craving; Hyperphagia; Orexigenic

Indexed keywords

CANNABINOID; ENDOCANNABINOID; NARCOTIC ANALGESIC AGENT;

ANIMAL; APPETITE; ARTICLE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; EATING; HOMEOSTASIS; HUMAN; HYPERALGESIA; METABOLISM; MOTIVATION; OBESITY; PAIN THRESHOLD; PATHOPHYSIOLOGY; PHYSIOLOGY; REWARD;

ANALGESICS, OPIOID; ANIMALS; APPETITE; CANNABINOIDS; EATING; ENDOCANNABINOIDS; HOMEOSTASIS; HUMANS; HYPERALGESIA; MOTIVATION; OBESITY; PAIN THRESHOLD; REWARD;

EID: 79952113954     PISSN: 18663370     EISSN: 18663389     Source Type: Book Series    
DOI: 10.1007/978-3-540-88955-7_9     Document Type: Article

References (99)

1. Abel EL (1971) Effects of marijuana on the solution of anagrams, memory and appetite. Nature 231:260-261
2. Acosta MC, Manubay J, Levin FR (2008) Pediatric obesity: parallels with addiction and treatment recommendations. Harv Rev Psychiatry. 16:80-96
3. Arnone M, Maruani J, Chaperon F et al. (1997) Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors. Psychopharmacology (Berlin) 132:104-106
4. Avraham Y, Ben Menachem A, Okun A et al. (2005) Effects of the endocannabinoid noladin ether on body weight, food consumption, locomotor activity, and cognitive index in mice. Brain Res Bull 65:117-123
5. Beck B (2007) Hypothalamic neuropeptides and feeding regulation. In: Kirkham TC, Cooper SJ (eds) Appetite and body weight: integrative systems and the development of anti-obesity drugs. Academic Press, Burlington, MA
6. Berridge KC (2000) Measuring hedonic impact in animals and infants: microstructure of affective taste reactivity patterns. Neurosci Biobehav Rev 24:173-198
7. Berridge KC (2007) Brain reward systems for food incentives hedonics in normal appetite and eating disorders. In: Kirkham TC, Cooper SJ (eds) Appetite and body weight: integrative systems and the development of anti-obesity drugs. Academic Press, Burlington, MA
8. Blundell JE, Jebb SA, Stubbs RJ et al. (2006) Effect of rimonabant on energy intake, motivation to eat and body weight with or without hypocaloric diet: the REBA study. International Congress on Obesity, Sydney, Australia (poster)
9. Bodnar RJ (2004) Endogenous opioids and feeding behavior: a 30-year historical perspective. Peptides 25:697-725
10. Cannon WB (1932) The wisdom of the body. WW Norton & Company, New York
11. Cani PD, Montoya ML, Neyrinck AM, Delzenne NM, Lambert DM (2004) Potential modulation of plasma ghrelin and glucagon-like peptide-l by anorexigenic cannabinoid compounds, SR141716A (rimonabant) and oleoylethanolamide. Br J Nutr 92:757-761
12. Chee MJ, Colmers WF (2008) Y eat? Nutrition 24:869-877
13. Chen R, Huang R, Shen C et al. (2004) Synergistic effects of cannabinoid inverse agonist AM251 and opioid antagonist nalmefene on food intake in mice. Brain Res Brain Res Rev 999:227-230
14. Colombo G, Agabio R, Diaz G et al. (1998) Appetite suppression and weight loss after the cannabinoid antagonist SR 141716. Life Sci 63:PL113-PL117
15. Cooper SJ, Kirkham TC (1993) Opioid mechanisms in the control of food consumption and taste preferences. In: Herz A, Akil H, Simon EJ (eds) Handbook of experimental pharmacology, vol. 104, part II. Springer, Berlin
16. Cota D, Marsicano G, Tschop M et al. (2003) The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J Clin Invest 112:423-431
17. Di Marzo V, Goparaju SK, Wang L et al. (2001) Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 410:822-825
18. Drewnowski A, Krahn DD, Demitrack MA et al. (1992) Taste responses and preferences for sweet high-fat foods: evidence for opioid involvement. Physiol Behav 51:371-379
19. Figlewicz Latteman D, Sanders NM, MacDonald A et al. (2007) Integration of peripheral adiposity signals and psychological controls of appetite. In: Kirkham TC, Cooper SJ (eds) Appetite and body weight: integrative systems and the development of anti-obesity drugs. Academic Press, Burlington, MA
20. Freedland CS, Poston JS, Porrino LJ (2000) Effects of SR141716A, a central cannabinoid receptor antagonist, on food-maintained responding. Pharmacol Biochem Behav 67:265-270
21. Gallate J, McGregor I (1999) The motivation for beer in rats: effects of ritanserin, naloxone and SR 141716. Psychopharmacology 142:302-308
22. Gallate J, Saharov T, Mallet P et al. (1999) Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist. Eur J Pharmacol 370:233-240
23. Gaoni Y, Mechoulam R (1971) The isolation and structure of delta-1-tetrahydrocannabinol and other neutral cannabinoids from hashish. J Am Chem Soc 93:217-224
24. Gardner E, Vorel S (1998) Cannabinoid transmission and reward-related events. Neurobiol Disease 5:502-533
25. Gibson EL, Brunstrom JM (2007) Learned influences on appetite, food choice, and intake: evidence in human beings. In: Kirkham TC, Cooper SJ (eds) Appetite and body weight: integrative systems and the development of anti-obesity drugs. Academic Press, Burlington, MA
26. Hao S, Avraham Y, Mechoulam R et al. (2000) Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice. Eur J Pharmacol 392:147-156
27. Harrold J, Elliott C, King P et al. (2002) Down-regulation of cannabinoid-1 (CB-1) receptors in specific extrahypothalamic regions of rats with dietary obesity: a role for endogenous cannabinoids in driving appetite for palatable food? Brain Res 952:232-238
28. Higgs S, Williams CM, Kirkham TC (2003) Cannabinoid influences on palatability: microstructural analysis of sucrose drinking after delta(9)-tetrahydrocannabinol, anandamide, 2-arachidonoyl glycerol and SR141716. Psychopharmacology (Berl) 165:370-377
29. Hildebrandt AL, Kelly-Sullivan DM, Black SC (2003) Antiobesity effects of chronic cannabinoid CB1 receptor antagonist treatment in diet-induced obese mice. Eur J Pharmacol 462:125-132
30. Jamshidi N, Taylor D (2001) Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats. Br J Pharmacol 134:1151-1154
31. Jarrett MM, Limebeer CL, Parker LA (2005) Effect of delta9-tetrahydrocannabinol on sucrose palatability as measured by the taste reactivity test. Physiol Behav 86:475-479
32. Jarrett MM, Scantlebury J, Parker LA (2007) Effect of delta(9)-tetrahydrocannabinol on quinine palatability and AM251 on sucrose and quinine palatability using the taste reactivity test. Physiol Behav 90:425-430
33. Kalra SP (2008) Central leptin insufficiency syndrome: an interactive etiology for obesity, metabolic and neural diseases and for designing new therapeutic interventions. Peptides 29:127-138
34. Kirkham TC (1990) Enhanced anorectic potency of naloxone in rats sham feeding 30% sucrose: reversal by repeated naloxone administration. Physiol Behav 47:419-426
35. Kirkham TC (2005) Endocannabinoids in the regulation of appetite and body weight. Behav Pharmacol 16:297-313
36. Kirkham TC, Cooper SJ (1988) Naloxone attenuation of sham feeding is modified by manipulation of sucrose concentration. Physiol Behav 44:491-494
37. Kirkham TC, Williams CM (2001a) Endogenous cannabinoids and appetite. Nutr Res Rev 14:65-86
38. Kirkham TC, Williams CM (2001b) Endocannabinoids: neuromodulators of food craving? In: Hetherington M (ed) Food cravings and addiction. Leatherhead Publishing, Leatherhead, UK
39. Kirkham TC, Williams CM (2001c) Synergistic effects of opioid and cannabinoid antagonists on food intake. Psychopharmacology (Berl) 153:267-270
40. Kirkham TC, Williams CM, Fezza F et al. (2002) Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. Br J Pharmacol 136:550-557
41. Koch JE, Matthews SM (2001) Delta9-tetrahydrocannabinol stimulates palatable food intake in Lewis rats: effects of peripheral and central administration. Nutr Neurosci 4:179-187
42. Kola B, Farkas I, Christ-Crain Met al. (2008) The orexigenic effect of ghrelin is mediated through central activation of the endogenous cannabinoid system. PLoS ONE 3:e1797
43. Konturek PC, Konturek JW, Czesnikiewicz-Guzik et al. (2005) Neuro-hormonal control food intake; basic mechanisms and clinical implications. J Physiol Pharmacol 56(Suppl 6):5-25
44. Leventhal L, Kirkham TC, Cole JL et al. (1995) Selective actions of central mu and kappa opioid antagonists upon sucrose intake in sham-fed rats. Brain Res 685:205-210
45. Levitsky DA (2002) Putting behavior back into feeding behavior: a tribute to George Collier. Appetite 38:143-148
46. Levitsky DA (2005) The non-regulation of food intake in humans: Hope for reversing the epidemic. 86:623-632
47. Lowe MR, Butryn ML (2007) Hedonic hunger: a new dimension of appetite? Physiol Behav 91:432-439
48. Mahler SV, Smith KS, Berridge KC (2007) Endocannabinoid hedonic hotspot for sensory pleasure: anandamide in nucleus accumbens shell enhances 'liking' of a sweet reward. Neuropsychopharmacology 32:2267-2278
49. Maljaars J, Peters HP, Masclee AM (2007) The gastrointestinal tract: neuroendocrine regulation of satiety and food intake. Aliment Pharmacol Ther 26(Suppl 2):241-250
50. Mari{dotless}́n Bivens CL, Thomas WJ, Stanley BG (1998) Similar feeding patterns are induced by perifornical neuropeptide Y injection and by food deprivation. Brain Res 782:271-280
51. Matias I, Cristino L, di Marzo V (2008) Endocannabinoids: some like it fat (and sweet too). J Neuroendocrinol 20(Suppl 1):100-109
52. Melis T, Succu S, Sanna F et al. (2007) The cannabinoid antagonist SR 141716A (Rimonabant) reduces the increase of extra-cellular dopamine release in the rat nucleus accumbens induced by a novel high palatable food. Neurosci Lett 419:231-235
53. Meschler JP, Howlett AC (2001) Signal transduction interactions between CB1 cannabinoid and dopamine receptors in the rat and a monkey striatum. Neuropharmacology 14:918-926
54. Miller CC, Murray TF, Freeman KG et al. (2004) Cannabinoid agonist, CP 55, 940, facilitates intake of palatable foods when injected into the hindbrain. Physiol Behav 80:611-616
55. Osei-Hyiamen D, DePetrillo M, Pacher P et al. (2005) Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. J Clin Invest 115:1298-1305
56. Pecina S, Berridge KC (2000) Opioid site in nucleus accumbens shell mediates eating and hedonic 'liking' for food: map based on microinjection Fos plumes. Brain Res 863:71-86
57. Pério A, Barnouin MC, Poncelet M et al. (2001) Activity of SR141716 on post-reinforcement pauses in operant responding for sucrose reward in rats. Behav Pharmacol 12:641-645
58. Pertwee RG (2008) Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond. Addict Biol 13(2):147-159
59. Pickel VM, Chan J, Kash TL et al. (2004) Compartment-specific localization of cannabinoid (CB1) and mu-opioid receptors in rat nucleus accumbens. Neuroscience 127:101-112
60. Pickel VM, Chan J, Kearn et al. (2006) Targeting dopamine D2 and cannabinoid-1 (CB-1) in rat nucleus accumbens. J Comp Neurol 495:299-313
61. Poncelet M, Maruani J, Calassi R et al. (2003) Overeating, alcohol and sucrose consumption decrease in CB1 receptor deleted mice. Neurosci Lett 343:216-218
62. Ravinet Trillou C, Arnone M, Delgorge C et al. (2003) Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice. Am J Physiol Regul Integr Comp Physiol 284: R345-R353
63. Riegel AC, Lupica CR (2004) Independent presynaptic and postsynaptic mechanisms regulate endocannabinoid signaling at multiple synapses in the ventral tegmental area. J Neurosci 24:11070-11078
64. Rinaldi-Carmona M, Barth F, Congy C et al. (2004) SR147778 [5-(4-Bromophenyl)-1-1(2, 4-dichlorophenyl)-4-ethyl-N-(1-piperidinyl)-1H-pyrazole-3-carboxamide], a new potent and selective antagonist of the CB1 cannabinoid receptor: biochemical and pharmacolo-gical characterization. J Pharmacol Exp Ther 310:905-914
65. Rolls BJ (1986) Sensory-specific satiety. Nutr Rev 44:93-101
66. RutkowskaM(2004) The effect of AM251, a cannabinoid CB1 receptor antagonist, on food intake in rats. Acta Pol Pharm 61:401-403
67. Sanchis-Segura C, Cline B, Marsicano G et al. (2004) Reduced sensitivity to reward in CB1 knockout mice. Psychopharmacology (Berl) 176:223-232
68. Scarpaci PJ, Zhang Y (2007) Elevated leptin: consequence or cause of obesity? Front Biosci 12:3531-3544
69. Shearman L, Rosko K, Fleischer R et al. (2003) Antidepressant-like and anorectic effects of the cannabinoid CB1 receptor inverse agonist AM251 in mice. Behav Pharmacol 14:573-582
70. Simiand J, Keane M, Keane P et al. (1998) SR 141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset. Behav Pharmacol 9:179-181
71. Solinas M, Goldberg SR (2005) Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems. Neuropsychopharmacology 30:2035-2045
72. Solinas M, Justinova Z, Goldberg SR et al. (2006) Anandamide administration alone and after inhibition of fatty acid amide hydrolase (FAAH) increases dopamine levels in the nuclear accumbens shell in rats. J. Neurochem 98:408-419
73. Solinas M, Goldberg SR, Piomelli D (2008) The endocannabinoid system in brain reward processes. Br J Pharmacol 154:369-383
74. Solinas M, Zangen A, Thiriet N, Goldberg SR (2004) b-endorphin elevations in the ventral tegmental area regulate the discriminative effects of D9-tetrahydrocannabinol. Eur J Neurosci 19:3183-3192
75. Soria-Gomez E, Matias I et al. (2007) Pharmacological enhancement of the endocannabinoid system in the nucleus accumbens shell stimulates food intake and increases c-Fos expression in the hypothalamus. Br J Pharmacol 151:1109-1116
76. Speakman JR (2007) Gene environment interactions and the origin of the modern obesity epidemic: a novel "nonadaptive drift" scenario. In: Kirkham TC, Cooper SJ (eds) Appetite and body weight: integrative systems and the development of anti-obesity drugs. Academic Press, Burlington, MA
77. Stratford TR (2007) The nucleus accumbens shell as a model of integrative subcortical forebrain systems regulating food intake. In: Kirkham TC, Cooper SJ (eds) Appetite and body weight: integrative systems and the development of anti-obesity drugs. Academic Press, Burlington, MA
78. Sullivan RJ, Hagen EH, Hammerstein P (2008) Revealing the paradox of drug reward in human evolution. Proc Biol Sci 275:1231-1241
79. Tallett AJ, Blundell JE et al. (2007a) Grooming, scratching and feeding: role of response competition in acute anorectic response to rimonabant in male rats. Psychopharmacology (Berl) 195:27-39
80. Tallett AJ, Blundell JE et al. (2007b) Acute anorectic response to cannabinoid CB1 receptor antagonist/inverse agonist AM 251 in rats: indirect behavioural mediation. Behav Pharmacol 18:591-600
81. Tart C (1970) Marijuana intoxication: common experiences. Nature 226:701-704
82. Tucci SA, Rogers EK, Korbonits M, Kirkham TC (2004) The cannabinoid CBI receptor antagonist SR141716 blocks the orexigenic effects of intrahypothalamic ghrelin. Br J Pharmacol 143:520-523
83. Valassi E, Scacchi M, Cavagnini F (2008) Neuroendocrine control of food intake. Nutr Metab Cardiovascular Dis 18:158-168
84. Valenti M, Viganòb D, Cascioa MG et al. (2004) Differential diurnal variations of anandamide and 2 arachidonoyl-glycerol levels in rat brain. Cell Mol Life Sci 61:945-950
85. van der Stelt M, Di Marzo V (2003) The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders. Eur J Pharmacol 480:133-150
86. Verty A, McGregor I, Mallet P (2004a) The dopamine receptor antagonist SCH 23390 attenuates feeding induced by Delta9-tetrahydrocannabinol. Brain Res 1020:188-195
87. Verty AN, McGregor IS, Mallet PE (2004b) Consumption of high carbohydrate, high fat, and normal chow is equally suppressed by a cannabinoid receptor antagonist in non-deprived rats. Neurosci Lett 354:217-220
88. Vickers S, Webster L, Wyatt A et al. (2003) Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats. Psychopharmacology (Berl) 167:103-111
89. Werner N, Koch J (2003) Effects of the cannabinoid antagonists AM281 and AM630 on deprivation-induced intake in Lewis rats. Brain Res 967:290-292
90. Wiley JL, Burston JJ, Leggett DC et al. (2005) CB(1) cannabinoid receptor-mediated modulation of food intake in mice. Br J Pharmacol 145:293-300
91. Williams CM, Kirkham TC (1999) Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors. Psychopharmacology (Berl) 143:315-317
92. Williams CM, Kirkham TC (2002a) Reversal of delta 9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine. Pharmacol Biochem Behav 71:333-340
93. Williams CM, Kirkham TC (2002b) Observational analysis of feeding induced by Delta9-THC and anandamide. Physiol Behav 76:241-250
94. Williams CM, Rogers PJ, Kirkham TC (1998) Hyperphagia in pre-fed rats following oral delta9 THC. Physiol Behav 65:343-346
95. Woods SC, Ramsay DS (2007) Homeostasis: beyond Curt Richter. Appetite 49(2):388-398
96. Wren AM, Bloom SR (2007) Gut hormones and appetite control. Gastroenterology 132:2116-2130
97. Yeomans MR (2007) The role of palatability in control of human appetite: implications for understanding and treating obesity. In: Kirkham TC, Cooper SJ (eds) Appetite and body weight: integrative systems and the development of anti-obesity drugs. Academic Press, Burlington, MA
98. Yeomans MR, Gray RW (1996) Selective effects of naltrexone on food pleasantness and intake. Physiol Behav 60:439-446
99. Zhou D, Shearman L (2004) Voluntary exercise augments acute effects of CB1-receptor inverse agonist on body weight loss in obese and lean mice. Pharmacol Biochem Behav 77:117-125